Literature DB >> 21077025

Toxicological risks of Chinese herbs.

Debbie Shaw1.   

Abstract

As traditional Chinese medicine (TCM) has become more popular there have been increasing concerns about safety and potential toxicity of the Chinese materia medica (CMM) comprising plants, animal parts and minerals. The potential toxicity of many CMM is well recognised in TCM and to reduce risks use of some herbs is restricted whilst specific processing methods have been developed to modify the activities/toxicity of others. However adverse reactions have been reported, many of these are due misuse or abuse of Chinese medicine. The main problem remains products adulterated with pharmaceuticals for weight loss or erectile dysfunction. But some herbs have narrow therapeutic ranges (e.g., Aconitum species) so toxic effects are frequently reported. Toxic effects from chronic or cumulative dosing are difficult to detect in the traditional setting and recent reports have demonstrated the health problems from Aristolochia species. Despite safety concerns, Chinese medicine appears to be relatively safe with comparatively few reports of adverse reactions compared with overall drug reports. The wealth of information in the Chinese literature needs to be more widely available. As TCM is widely used by patients, improved pharmacovigilance and pharmacoepidemiology can contribute valuable safety information, relevant to clinical use. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21077025     DOI: 10.1055/s-0030-1250533

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  40 in total

1.  Aconite poisoning over 5 years: a case series in Hong Kong and lessons towards herbal safety.

Authors:  Sammy Pak Lam Chen; Sau Wah Ng; Wing Tat Poon; Chi Kong Lai; Teresa Man Shan Ngan; Man Li Tse; Thomas Yan Keung Chan; Albert Yan Wo Chan; Tony Wing Lai Mak
Journal:  Drug Saf       Date:  2012-07-01       Impact factor: 5.606

Review 2.  An overview on adverse drug reactions to traditional Chinese medicines.

Authors:  Kelvin Chan; Hongwei Zhang; Zhi-Xiu Lin
Journal:  Br J Clin Pharmacol       Date:  2015-05-19       Impact factor: 4.335

3.  Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells.

Authors:  Shou-jin Dong; Yun-qing Zhong; Wen-ting Lu; Guan-hong Li; Hong-li Jiang; Bing Mao
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

4.  A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine.

Authors:  Da Yuan; Xue Yang; Jun-Chao Guo
Journal:  J Zhejiang Univ Sci B       Date:  2016-05       Impact factor: 3.066

Review 5.  Current regulatory guidelines and resources to support research of dietary supplements in the United States.

Authors:  Regan L Bailey
Journal:  Crit Rev Food Sci Nutr       Date:  2018-11-13       Impact factor: 11.176

Review 6.  Dietary Supplements with Antiplatelet Activity: A Solution for Everyone?

Authors:  Beata Olas
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

Review 7.  Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.

Authors:  Rolf Teschke; Dominique Larrey; Dieter Melchart; Gaby Danan
Journal:  Medicines (Basel)       Date:  2016-07-19

Review 8.  Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Axel Eickhoff; Johannes Schulze
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 9.  Safety surveillance of traditional Chinese medicine: current and future.

Authors:  Shwu-Huey Liu; Wu-Chang Chuang; Wing Lam; Zaoli Jiang; Yung-Chi Cheng
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

Review 10.  Nephrotoxicity and Chinese Herbal Medicine.

Authors:  Bo Yang; Yun Xie; Maojuan Guo; Mitchell H Rosner; Hongtao Yang; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.